See LEGEND for key to shading and symbols.
Subject Area - PHAR Term - Term 1 2019
| PHAR3102 | PHAR3111 | PHAR3251 | PHAR9101 | PHAR9111 | PHAR9113 |
| PHAR9120 | PHAR9124 |
Data is correct as at Sun 22 Sep 19:04:54 AEST 2019
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| PHAR3102 | Molecular Pharmacology | ||||||
| CRS | CR01 | 2212 | Open | 0/6 | 0% | (Course Enrolment, UGRD) | |
| LAB | H10A | 7693 | Enr | Open | 34/35 | 97% | Tue 10-13 (w11, Wurth 120); Thu 10-13 (w1-9, Wurth 120) |
| LAB | H14A | 7694 | Enr | Open | 30/35 | 86% | Tue 14-17 (w11, Wurth 120); Thu 14-17 (w1-9, Wurth 120) |
| LEC | A | 7692 | Rel | Open | 64/70 | 91% | Tue 17 (w1-10, CLB 3); Wed 09 (w1-10, WurthLG03) |
| TUT | W10A | 7695 | Rel | Open | 33/35 | 94% | Wed 10 (w1-10, Mat 232) |
| TUT | W11A | 7696 | Rel | Open | 31/35 | 89% | Wed 11 (w1-10, Mat 232) |
| PHAR3111 | Clinical Pharmacology for HESC | ||||||
| CRS | CR01 | 2713 | Open | 0/4 | 0% | (Course Enrolment, UGRD) | |
| LAB | H10A | 9530 | Enr | Open | 100/104 | 96% | Thu 10-13 (w1-10, Wurth 115) |
| LEC | A | 9529 | Rel | Open | 100/104 | 96% | Tue 12 (w1-10, WurthLG03); Wed 11 (w1-10, WurthLG03); Wed 12 (w11, Vall 121); Fri 12 (w1-8,10, Vall 121) |
| TUT | W12A | 9531 | Rel | Open | 47/50 | 94% | Wed 12 (w1-10, Mat 309) |
| TUT | W13A | 9532 | Rel | Open | 53/54 | 98% | Wed 13 (w1-10, Mat 102) |
| PHAR3251 | Clinical & Exp'l Pharmacology | ||||||
| CRS | CR01 | 2102 | Open | 0/7 | 0% | (Course Enrolment, UGRD) | |
| LAB | M11A | 5480 | Enr | Open | 63/70 | 90% | Mon 11-14 (w1-9,11, Wurth 115) |
| LEC | A | 5479 | Rel | Open | 63/70 | 90% | Mon 09 (w1-9,11, WurthLG03); Tue 13 (w1-10, CLB 3) |
| TUT | T14A | 5481 | Rel | Open | 34/35 | 97% | Tue 14 (w1-10, Mat 105) |
| TUT | T15A | 5482 | Rel | Open | 29/35 | 83% | Tue 15 (w1-10, Mat 105) |
| PHAR9101 | Intro to Therapeutics Industry | ||||||
| CRS | CR01 | 1263 | Open | 0/5 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10259 | Enr | Open | 15/20 | 75% | |
| PHAR9111 | Pharmaceutics | ||||||
| CRS | CR01 | 1271 | Open | 0/11 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10260 | Enr | Open | 9/20 | 45% | |
| PHAR9113 | InternationalRegulatoryAffairs | ||||||
| CRS | CR01 | 1170 | Open | 0/8 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10261 | Enr | Open | 12/20 | 60% | |
| PHAR9120 | Clinical Trials | ||||||
| CRS | CR01 | 1217 | Open | 0/11 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10262 | Enr | Open | 9/20 | 45% | |
| PHAR9124 | Internship | ||||||
| CRS | CR01 | 1135 | Open* | 0/10 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10263 | Enr | Open* | 0/10 | 0% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |